- NEWS
Alzheimer’s drug trials plagued by lack of racial diversity
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 620, 256-257 (2023)
doi: https://doi.org/10.1038/d41586-023-02464-1
References
van Dyck, C. H. et al. N. Engl. J. Med. 388, 9–21 (2023).
Sims, J. R. et al. JAMA https://doi.org/10.1001/jama.2023.13239 (2023).
Grill, J. et al. Alzheimers Dement. 18, e069198 (2022).
Le Guen, Y. et al. JAMA https://doi.org/10.1001/jama.2023.0268 (2023).
Naslavsky, M.S. et al. Mol. Psychiatry 27, 4800–4808 (2022).